Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 26 million sales milestone payments to BasileaGlobeNewsWire • 06/08/23
Phase 3 Studies of Pfizer's Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsBusiness Wire • 06/01/23
Dividend Harvesting Portfolio Week 117: $11,700 Allocated, $980.26 In Projected DividendsSeeking Alpha • 06/01/23
Excision BioTherapeutics Appoints Former Pfizer Chairman and CEO Jeffrey B. Kindler to its Board of DirectorsGlobeNewsWire • 06/01/23
U.S. FDA Approves ABRYSVO™, Pfizer's Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older AdultsBusiness Wire • 05/31/23